Kiromic Biopharma Inc banner

Kiromic Biopharma Inc
OTC:KRBP

Watchlist Manager
Kiromic Biopharma Inc Logo
Kiromic Biopharma Inc
OTC:KRBP
Watchlist
Price: 0.0403 USD Market Closed
Market Cap: $10k

Cash Flow Statement

Cash Flow Statement
Kiromic Biopharma Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024
Operating Cash Flow
Net Income
(28)
(19)
(26)
(29)
(33)
(38)
(35)
(33)
(31)
(23)
(21)
(22)
(22)
(25)
(27)
Depreciation & Amortization
0
0
0
1
1
1
2
2
2
2
2
2
2
2
2
Stock-Based Compensation
5
6
4
3
2
1
1
0
(0)
(0)
0
0
0
0
1
Other Non-Cash Items
15
5
4
3
2
2
5
5
5
5
1
1
0
1
1
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(0)
(1)
1
(0)
2
6
4
5
3
(3)
(3)
(4)
(5)
1
4
Cash from Operating Activities
(12)
N/A
(14)
-10%
(20)
-48%
(25)
-24%
(28)
-9%
(29)
-5%
(24)
+18%
(20)
+15%
(21)
-2%
(20)
+4%
(21)
-7%
(23)
-7%
(25)
-8%
(21)
+13%
(19)
+8%
Investing Cash Flow
Capital Expenditures
(2)
(1)
(2)
(4)
(6)
(6)
(5)
(2)
0
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
(2)
N/A
(1)
+43%
(2)
-56%
(4)
-135%
(6)
-45%
(6)
+4%
(5)
+18%
(2)
+51%
0
N/A
(0)
N/A
(0)
-40%
(0)
-10%
(0)
-43%
(0)
-37%
(0)
+18%
Financing Cash Flow
Net Issuance of Common Stock
18
55
40
0
40
0
0
0
1
1
1
0
0
0
0
Net Issuance of Debt
0
0
0
0
0
0
4
10
17
24
23
24
26
20
18
Other
0
(6)
(3)
0
0
0
(0)
(1)
(0)
(0)
(0)
0
0
(0)
0
Cash from Financing Activities
16
N/A
50
+217%
37
-25%
37
0%
37
0%
0
-100%
4
+38 900%
10
+146%
17
+76%
24
+42%
24
0%
25
+3%
26
+7%
20
-23%
18
-9%
Change in Cash
Net Change in Cash
1
N/A
35
+2 943%
15
-56%
8
-49%
3
-56%
(35)
N/A
(25)
+29%
(13)
+47%
(4)
+71%
4
N/A
3
-35%
2
-37%
1
-9%
(1)
N/A
(1)
-6%
Free Cash Flow
Free Cash Flow
(15)
N/A
(15)
-3%
(22)
-48%
(30)
-33%
(34)
-14%
(35)
-3%
(29)
+18%
(23)
+21%
(21)
+9%
(20)
+3%
(21)
-7%
(23)
-7%
(25)
-8%
(22)
+13%
(20)
+8%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett